Perbedaan Kalbe Farma Tbk dan Charlie Hospital Semarang Tbk.: Kalbe Farma Tbk diperdagangkan di Rp720 (kapitalisasi pasar 33 T, volume 24 jam 98,44 jt), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp258 (kapitalisasi pasar 678,4 M, volume 24 jam 25,57 jt). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 48,6× kapitalisasi pasar Charlie Hospital Semarang Tbk., dan Kalbe Farma Tbk lebih aktif diperdagangkan (98,44 jt vs 25,57 jt). Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 33 T | 678,4 M |
Volume | 98,44 jt | 25,57 jt |
Lot | 984,38 rb | 255,67 rb |
Perputaran | 70,64 M | 6,57 M |
Harga Rata-rata | 717,58 | 256,8 |
Nilai Transaksi | 70,64 M | 6,57 M |
Harga Ekuilibrium Indikatif | 720 | 258 |
Volume Ekuilibrium Indikatif | 43,62 rb | 110 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →